Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19.
COVID-19
dermatology
eruption
infectious disease
obstetric medicine
pregnancy
skin
vaccine
Journal
International journal of women's dermatology
ISSN: 2352-6475
Titre abrégé: Int J Womens Dermatol
Pays: United States
ID NLM: 101654170
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
07
05
2021
revised:
21
08
2021
accepted:
22
08
2021
pubmed:
1
9
2021
medline:
1
9
2021
entrez:
31
8
2021
Statut:
ppublish
Résumé
The care for patients infected with COVID-19 requires a team approach, and dermatologists may collaborate with other specialties, especially infectious disease (ID) medicine and obstetrics and gynecology (ObGyn), at every stage of the infection process. A broad spectrum of cutaneous manifestations may occur early in COVID-19 infection, making appropriate dermatologic identification critical for an early diagnosis. There is prognostic value in appropriately identifying different types of COVID-19-associated skin manifestations, which have been linked to disease severity. Such observations emanated from dermatology research, especially large series and international registries of cutaneous manifestations relating to COVID-19, and impact COVID-19 care provided by most health care providers. Also, research based on international registries of skin reactions from the COVID-19 vaccines has an impact across disciplines. An increased risk for severe illness from COVID-19 is encountered during pregnancy, and dermatologists' role is to urge ObGyn and other clinicians to monitor and educate pregnant patients about the potential for eruptions as a manifestation of COVID-19. ID and ObGyn experts indicate that teledermatology enhanced the interaction among health care providers and improved COVID-19 care. More than 40% of all dermatology consultations at a tertiary care hospital were done via teledermatology. Future collaborative research involving dermatology and specialties, such as ID and ObGyn, could help delineate guidelines for dermatology consultations in patients infected with COVID-19 and determine cases appropriate for teledermatology.
Identifiants
pubmed: 34462725
doi: 10.1016/j.ijwd.2021.08.008
pii: S2352-6475(21)00101-5
pmc: PMC8388141
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
640-646Informations de copyright
© 2021 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest. Eleftherios Mylonakis was involved in clinical trials on COVID-19. These trials were supported by Regeneron, NIH, and SciClone Pharmaceuticals, Inc. All funds were to the institution, and Eleftherios Mylonakis received no direct funds.
Références
J Am Acad Dermatol. 2020 Jul;83(1):e69-e71
pubmed: 32339708
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293
pubmed: 32330334
Front Med (Lausanne). 2021 Feb 16;8:634208
pubmed: 33665200
FASEB J. 2019 Feb;33(2):2599-2609
pubmed: 30281335
Int J Antimicrob Agents. 2020 Aug;56(2):106024
pubmed: 32450197
J Eur Acad Dermatol Venereol. 2020 May;34(5):e210-e211
pubmed: 32201983
Clin Dermatol. 2021 May-Jun;39(3):451-456
pubmed: 34518003
Am J Clin Dermatol. 2020 Oct;21(5):627-639
pubmed: 32865778
Clin Dermatol. 2016 May-Jun;34(3):320-6
pubmed: 27265069
Healthcare (Basel). 2020 Oct 01;8(4):
pubmed: 33019667
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e536-e537
pubmed: 32453865
Br J Dermatol. 2020 Oct;183(4):784-785
pubmed: 32613638
Br J Dermatol. 2020 Jul;183(1):71-77
pubmed: 32348545
Br J Dermatol. 2021 May;184(5):880-887
pubmed: 33448030
Dermatopathology (Basel). 2020 Jun 30;7(1):3-16
pubmed: 32608380
Am J Obstet Gynecol. 2020 Jun;222(6):521-531
pubmed: 32217113
Lancet Infect Dis. 2021 Mar;21(3):313-314
pubmed: 33460566
Clin Dermatol. 2021 May-Jun;39(3):479-487
pubmed: 34518007
J Am Acad Dermatol. 2021 Jul;85(1):46-55
pubmed: 33838206
Dermatol Ther. 2020 Nov;33(6):e13883
pubmed: 32578309
BMJ Case Rep. 2021 Jan 6;14(1):
pubmed: 33408113
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
Eur J Endocrinol. 2021 May;184(5):637-645
pubmed: 33635829
Dermatol Ther. 2020 Jul;33(4):e13562
pubmed: 32396251
Front Immunol. 2020 Jul 07;11:1672
pubmed: 32733490
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452
pubmed: 32339344
JAMA Dermatol. 2020 Sep 1;156(9):998-1003
pubmed: 32584377
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e359-e361
pubmed: 33651424
J Cosmet Dermatol. 2020 Jul;19(7):1545-1547
pubmed: 32301221
Dermatol Ther. 2020 Nov;33(6):e14170
pubmed: 32779280
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2505-2510
pubmed: 32594572
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e13-e15
pubmed: 32977363
Cleve Clin J Med. 2020 May 14;:
pubmed: 32409442
Dermatol Ther. 2020 Jul;33(4):e13773
pubmed: 32506600
J Leukoc Biol. 2021 Jan;109(1):55-66
pubmed: 32930456
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e559-e561
pubmed: 32500642
J Invest Dermatol. 2021 Jan;141(1):206-209.e1
pubmed: 32454066
Dermatol Ther. 2020 Jul;33(4):e13758
pubmed: 32495994
J Am Acad Dermatol. 2020 May;82(5):e173-e175
pubmed: 32224277
J Leukoc Biol. 2006 Jul;80(1):117-24
pubmed: 16670123
Br J Dermatol. 2021 Aug;185(2):445-447
pubmed: 33893637
Dermatol Ther. 2020 Sep;33(5):e13521
pubmed: 32378315
Am J Obstet Gynecol. 2011 Jul;205(1):10-8
pubmed: 21345415
Int J Dermatol. 2020 Oct;59(10):1278-1279
pubmed: 32880974
J Am Acad Dermatol. 2020 Oct;83(4):1118-1129
pubmed: 32622888
J Am Acad Dermatol. 2018 Oct;79(4):617-633
pubmed: 30241624
Dermatol Ther. 2020 Nov;33(6):e14117
pubmed: 32737915
Am J Case Rep. 2021 Mar 20;22:e929489
pubmed: 33743006
Int J Womens Dermatol. 2021 Mar;7(2):217-223
pubmed: 33072835
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e541-e542
pubmed: 32441876
Dermatol Ther. 2020 Nov;33(6):e14290
pubmed: 32902087
Am J Perinatol. 2020 Jun;37(8):773-779
pubmed: 32303077
J Am Acad Dermatol. 2021 Jan;84(1):156-158
pubmed: 33189415
Dermatol Ther. 2020 Sep;33(5):e13420
pubmed: 32297408
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Int J Dermatol. 2020 Nov;59(11):1358-1370
pubmed: 32936462
Am J Obstet Gynecol. 2021 Apr;224(4):389.e1-389.e9
pubmed: 32986989
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776
Cutis. 2020 Dec;106(6):318-320
pubmed: 33471879
J Am Acad Dermatol. 2020 Aug;83(2):486-492
pubmed: 32479979
JAAD Int. 2021 Mar;2:119-133
pubmed: 33479703
Rheumatology (Oxford). 2021 Jan 5;60(1):479-480
pubmed: 33206974
Int J Mol Sci. 2020 Apr 22;21(8):
pubmed: 32331343
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Int J Dermatol. 2020 Jul;59(7):874-875
pubmed: 32358979
Biomed Res Int. 2020 Jul 5;2020:1236520
pubmed: 32724793
J Cutan Med Surg. 2021 Mar-Apr;25(2):169-176
pubmed: 33179534
Clin Case Rep. 2020 Dec 18;9(2):830-834
pubmed: 33598253
JAMA Pediatr. 2021 Aug 1;175(8):817-826
pubmed: 33885740
Dermatol Ther. 2020 Nov;33(6):e14161
pubmed: 32770716
Int J Dermatol. 2021 Jul;60(7):e267-e268
pubmed: 33650165
Dermatol Ther. 2020 Jul;33(4):e13523
pubmed: 32378293
J Am Acad Dermatol. 2021 May;84(5):1356-1363
pubmed: 33476725
BMJ Case Rep. 2021 Apr 7;14(4):
pubmed: 33827885
Dermatol Ther. 2021 Mar;34(2):e14753
pubmed: 33406308